Welcome : Guest

BioSpecifics Technologies Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about BioSpecifics Technologies Corporation, which is principally involved in the Manufacture and Distribution of Biopharmaceuticals. Illustrated with 19 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-31367
Price: $950
Company Type: Public
Pages: 21
Date: October 2015
Market Data Tables: 19

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
  BIOSPECIFICS TECHNOLOGIES CORPORATION (USA) (Complete Report)Pages : 21|$ 950.00
1. COMPANY SNIPPETS......1
2. SALES DATA......2
Table 1: BioSpecifics Technologies Corporation’s Revenues by Category Worldwide (2013) in Percentage for Net Sales, Royalties, Licensing Revenue and Consulting Fees......2
3. MARKET OVERVIEW......3
Biopharmaceuticals......3
Table 2: Biopharmaceuticals Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......3
Biologics......4
Table 3: Biological Drugs Market by Product Segment Worldwide (2015)-Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......4
Table 4: Biologics Therapeutic Classes Market by Category in China (2014) – Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......5
Table 5: Dermatology Biologics Market by Product Type Worldwide (2014) – Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......6
Table 6: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......7
Table 7: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......8
Biosimilars......9
Table 8: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......9
Injectables......10
Table 9: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......10
Table 10: Injectables Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......11
Urology Drugs......12
Table 11: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......12
4. COMPETITIVE LANDSCAPE......13
Biopharmaceuticals......13
Table 12: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A., and Others......13
Biosimilars......14
Table 13: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015)-Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......14
Injectables......15
Table 14: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......15
Table 15: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......16
Table 16: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......17
Table 17: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......18
Table 18: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......19
Erectile Dysfunction Drugs......20
Table 19: Market Shares of Leading Erectile Dysfunction (ED) Drug Brands by Value Sales in Korea (2014) - Percentage Breakdown for Cialis, Levitra, Mvix, Viagra, Yaila, and Zydena......20
5. RECENT INDUSTRY DEVELOPMENTS......21